









Markets
/
Stocks
/
nasdaq-entx
/

Entera Bio Ltd

ENTX

View Detailed Chart

1.950USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

88.57MMarket Cap

LossP/E TTM



Entera Bio Ltd

1.950

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

+1.04%

5 Days

+4.84%

1 Month

+3.17%

6 Months

-6.70%

Year to Date

-8.02%

1 Year

+25.81%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts

BUY

Current Rating

10.000

Target Price

412.82%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Entera Bio Ltd

ENTX

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(8)

Neutral(3)

Buy(2)

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.012

Buy

RSI(14)

49.972

Neutral

STOCH(KDJ)(9,3,3)

23.048

Neutral

ATR(14)

0.136

Low Volatility

CCI(14)

-44.705

Neutral

Williams %R

67.797

Sell

TRIX(12,20)

0.099

Sell

StochRSI(14)

15.026

Sell

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

1.996

Sell

MA10

1.962

Sell

MA20

1.922

Buy

MA50

1.951

Sell

MA100

1.950

Sell

MA200

2.001

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.

Ticker SymbolENTX

CompanyEntera Bio Ltd

CEOMs. Miranda Jayne Toledano

Websitehttps://enterabio.com/